Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-05

AUTHORS

Robert P. Giugliano

ABSTRACT

Over the past decade, several glycoprotein IIb/IIIa receptor antagonists have been developed and tested clinically as adjuncts to coronary intervention and/or treatment of acute coronary syndromes. Thrombocytopenia associated with this class of compounds has been described in most large studies to date and when it occurs in combination with bleeding represents a major safety concern. Cases of thrombocytopenia caused by GP IIb/IIIa antagonists vary in their clinical presentation according to time of onset (following the first dose or delayed), severity (profound, i.e., <20,000 cells/mm(3), or mild), and may or may not be associated with clinically important bleeding. More than one etiology appears responsible for thrombocytopenia associated with GP IIb/IIIa antagonists, including acute, idiosyncratic, as well as delayed immune-mediated mechanisms. Comparison of the incidence of thrombocytopenia across the different agents currently being studied and the one agent commercially available is complicated by varying definitions of thrombocytopenia used to date; different clinical settings in which GP IIb/IIIa antagonists have been studied; use of concomitant medications such as heparin, which itself may cause thrombocytopenia; relatively infrequent occurrence of thrombocytopenia; and the limited number of patients exposed to these agents. Review of the large studies presented and published to date suggests that thrombocytopenia due specifically to GP IIb/IIIa receptor antagonists occurs in less than 5% of treated patients and may vary depending on the type of agent, concomitant therapy, and clinical scenario. Current standard management includes immediate cessation of the GP IIb/IIIa antagonist and, in severe cases, platelet transfusions. In cases with associated hemorrhage, other anticoagulants and antiplatelet agents should be discontinued and possibly reversed. There may be a role for IV IgG and steroids, especially for cases of thrombocytopenia that are immune-mediated; however, further investigations are necessary. More... »

PAGES

191-202

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1008887708104

DOI

http://dx.doi.org/10.1023/a:1008887708104

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028310016

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10767115


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "TIMI Study Chairman\u2019s Office, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giugliano", 
        "givenName": "Robert P.", 
        "id": "sg:person.0702207604.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702207604.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1995.tb08346.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010142341"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(96)90072-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011240930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.107.5.711", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014069980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199706123362401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017752478"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000441-197402000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019682362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000441-197402000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019682362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)92558-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021469486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)92558-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021469486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9610(91)90183-e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023228319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199011223232114", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023817201"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ajh.2830060204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024110883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0735-1097(94)90634-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025598401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0735-1097(93)90041-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030203168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(96)81843-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031889596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(96)81843-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031889596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(94)90474-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033229922"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.97.4.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034721348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199404073301402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040255966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.108.4_supplement.258s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042476702"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197903223001215", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042550389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0735-1097(95)00500-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043295572"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.22.6.440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043678204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(96)10452-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044275166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197607292950501", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047017208"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199105303242206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048753262"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(96)10172-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049786560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(96)80531-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052868078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(96)80531-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052868078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0268-960x(88)90032-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053187605"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(97)84111-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054658363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm00042a007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055933431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.91.8.2151", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063336211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.94.5.899", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063337444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.94.5.906", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063337445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.95.4.846", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063337843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-126-4-199702150-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073701186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0889-8588(18)30515-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077282481"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077553458", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-198805000-00018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079707891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-198805000-00018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079707891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-198805000-00018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079707891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081782721", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082829483", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-05", 
    "datePublishedReg": "1998-05-01", 
    "description": "Over the past decade, several glycoprotein IIb/IIIa receptor antagonists have been developed and tested clinically as adjuncts to coronary intervention and/or treatment of acute coronary syndromes. Thrombocytopenia associated with this class of compounds has been described in most large studies to date and when it occurs in combination with bleeding represents a major safety concern. Cases of thrombocytopenia caused by GP IIb/IIIa antagonists vary in their clinical presentation according to time of onset (following the first dose or delayed), severity (profound, i.e., <20,000 cells/mm(3), or mild), and may or may not be associated with clinically important bleeding. More than one etiology appears responsible for thrombocytopenia associated with GP IIb/IIIa antagonists, including acute, idiosyncratic, as well as delayed immune-mediated mechanisms. Comparison of the incidence of thrombocytopenia across the different agents currently being studied and the one agent commercially available is complicated by varying definitions of thrombocytopenia used to date; different clinical settings in which GP IIb/IIIa antagonists have been studied; use of concomitant medications such as heparin, which itself may cause thrombocytopenia; relatively infrequent occurrence of thrombocytopenia; and the limited number of patients exposed to these agents. Review of the large studies presented and published to date suggests that thrombocytopenia due specifically to GP IIb/IIIa receptor antagonists occurs in less than 5% of treated patients and may vary depending on the type of agent, concomitant therapy, and clinical scenario. Current standard management includes immediate cessation of the GP IIb/IIIa antagonist and, in severe cases, platelet transfusions. In cases with associated hemorrhage, other anticoagulants and antiplatelet agents should be discontinued and possibly reversed. There may be a role for IV IgG and steroids, especially for cases of thrombocytopenia that are immune-mediated; however, further investigations are necessary.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1023/a:1008887708104", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "name": "Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors?", 
    "pagination": "191-202", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "86dd08fd15560cfa62537fbf0cc70118692ce904ec017f5d6aaa2e0923dd1667"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10767115"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1008887708104"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028310016"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1008887708104", 
      "https://app.dimensions.ai/details/publication/pub.1028310016"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000500.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1023/A:1008887708104"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1008887708104'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1008887708104'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1008887708104'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1008887708104'


 

This table displays all metadata directly associated to this object as RDF triples.

177 TRIPLES      21 PREDICATES      66 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1008887708104 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N57c9ac7177574ae3ba0f0b3372a90ad6
4 schema:citation https://app.dimensions.ai/details/publication/pub.1077553458
5 https://app.dimensions.ai/details/publication/pub.1081782721
6 https://app.dimensions.ai/details/publication/pub.1082829483
7 https://doi.org/10.1002/ajh.2830060204
8 https://doi.org/10.1016/0002-9149(94)90474-x
9 https://doi.org/10.1016/0002-9610(91)90183-e
10 https://doi.org/10.1016/0140-6736(90)92558-y
11 https://doi.org/10.1016/0268-960x(88)90032-x
12 https://doi.org/10.1016/0735-1097(93)90041-x
13 https://doi.org/10.1016/0735-1097(94)90634-3
14 https://doi.org/10.1016/0735-1097(95)00500-5
15 https://doi.org/10.1016/s0002-9149(96)90072-7
16 https://doi.org/10.1016/s0140-6736(96)10172-0
17 https://doi.org/10.1016/s0140-6736(96)10452-9
18 https://doi.org/10.1016/s0735-1097(96)80531-6
19 https://doi.org/10.1016/s0735-1097(96)81843-2
20 https://doi.org/10.1016/s0735-1097(97)84111-3
21 https://doi.org/10.1016/s0889-8588(18)30515-x
22 https://doi.org/10.1021/jm00042a007
23 https://doi.org/10.1056/nejm197607292950501
24 https://doi.org/10.1056/nejm197903223001215
25 https://doi.org/10.1056/nejm199011223232114
26 https://doi.org/10.1056/nejm199105303242206
27 https://doi.org/10.1056/nejm199404073301402
28 https://doi.org/10.1056/nejm199706123362401
29 https://doi.org/10.1084/jem.107.5.711
30 https://doi.org/10.1097/00000441-197402000-00008
31 https://doi.org/10.1097/00007611-198805000-00018
32 https://doi.org/10.1111/j.1365-2141.1995.tb08346.x
33 https://doi.org/10.1136/ard.22.6.440
34 https://doi.org/10.1161/01.cir.91.8.2151
35 https://doi.org/10.1161/01.cir.94.5.899
36 https://doi.org/10.1161/01.cir.94.5.906
37 https://doi.org/10.1161/01.cir.95.4.846
38 https://doi.org/10.1161/01.cir.97.4.340
39 https://doi.org/10.1378/chest.108.4_supplement.258s
40 https://doi.org/10.7326/0003-4819-126-4-199702150-00010
41 schema:datePublished 1998-05
42 schema:datePublishedReg 1998-05-01
43 schema:description Over the past decade, several glycoprotein IIb/IIIa receptor antagonists have been developed and tested clinically as adjuncts to coronary intervention and/or treatment of acute coronary syndromes. Thrombocytopenia associated with this class of compounds has been described in most large studies to date and when it occurs in combination with bleeding represents a major safety concern. Cases of thrombocytopenia caused by GP IIb/IIIa antagonists vary in their clinical presentation according to time of onset (following the first dose or delayed), severity (profound, i.e., <20,000 cells/mm(3), or mild), and may or may not be associated with clinically important bleeding. More than one etiology appears responsible for thrombocytopenia associated with GP IIb/IIIa antagonists, including acute, idiosyncratic, as well as delayed immune-mediated mechanisms. Comparison of the incidence of thrombocytopenia across the different agents currently being studied and the one agent commercially available is complicated by varying definitions of thrombocytopenia used to date; different clinical settings in which GP IIb/IIIa antagonists have been studied; use of concomitant medications such as heparin, which itself may cause thrombocytopenia; relatively infrequent occurrence of thrombocytopenia; and the limited number of patients exposed to these agents. Review of the large studies presented and published to date suggests that thrombocytopenia due specifically to GP IIb/IIIa receptor antagonists occurs in less than 5% of treated patients and may vary depending on the type of agent, concomitant therapy, and clinical scenario. Current standard management includes immediate cessation of the GP IIb/IIIa antagonist and, in severe cases, platelet transfusions. In cases with associated hemorrhage, other anticoagulants and antiplatelet agents should be discontinued and possibly reversed. There may be a role for IV IgG and steroids, especially for cases of thrombocytopenia that are immune-mediated; however, further investigations are necessary.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree false
47 schema:isPartOf N98ca217150544609962189e09c4a5915
48 Nb9b9a0b93fcf4c9093b8538269c0e2a7
49 sg:journal.1113719
50 schema:name Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors?
51 schema:pagination 191-202
52 schema:productId N4bb830602e1c4042979562114c94fdfe
53 N4e0526b48be34dea9ddb3160b6c9479b
54 N7253e735f3b14607b4ec35cf71baeea7
55 Nd336e1ebbc5d462abc10955b3dcc0d8b
56 Nf23dee9a258e4a588477c1ec7183b1c5
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028310016
58 https://doi.org/10.1023/a:1008887708104
59 schema:sdDatePublished 2019-04-11T00:13
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher Nf4d82268353f461fb9c21b8b2edff946
62 schema:url http://link.springer.com/10.1023/A:1008887708104
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N4bb830602e1c4042979562114c94fdfe schema:name dimensions_id
67 schema:value pub.1028310016
68 rdf:type schema:PropertyValue
69 N4e0526b48be34dea9ddb3160b6c9479b schema:name readcube_id
70 schema:value 86dd08fd15560cfa62537fbf0cc70118692ce904ec017f5d6aaa2e0923dd1667
71 rdf:type schema:PropertyValue
72 N57c9ac7177574ae3ba0f0b3372a90ad6 rdf:first sg:person.0702207604.00
73 rdf:rest rdf:nil
74 N7253e735f3b14607b4ec35cf71baeea7 schema:name doi
75 schema:value 10.1023/a:1008887708104
76 rdf:type schema:PropertyValue
77 N98ca217150544609962189e09c4a5915 schema:volumeNumber 5
78 rdf:type schema:PublicationVolume
79 Nb9b9a0b93fcf4c9093b8538269c0e2a7 schema:issueNumber 3
80 rdf:type schema:PublicationIssue
81 Nd336e1ebbc5d462abc10955b3dcc0d8b schema:name nlm_unique_id
82 schema:value 9502018
83 rdf:type schema:PropertyValue
84 Nf23dee9a258e4a588477c1ec7183b1c5 schema:name pubmed_id
85 schema:value 10767115
86 rdf:type schema:PropertyValue
87 Nf4d82268353f461fb9c21b8b2edff946 schema:name Springer Nature - SN SciGraph project
88 rdf:type schema:Organization
89 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
90 schema:name Medical and Health Sciences
91 rdf:type schema:DefinedTerm
92 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
93 schema:name Cardiorespiratory Medicine and Haematology
94 rdf:type schema:DefinedTerm
95 sg:journal.1113719 schema:issn 0929-5305
96 1573-742X
97 schema:name Journal of Thrombosis and Thrombolysis
98 rdf:type schema:Periodical
99 sg:person.0702207604.00 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
100 schema:familyName Giugliano
101 schema:givenName Robert P.
102 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702207604.00
103 rdf:type schema:Person
104 https://app.dimensions.ai/details/publication/pub.1077553458 schema:CreativeWork
105 https://app.dimensions.ai/details/publication/pub.1081782721 schema:CreativeWork
106 https://app.dimensions.ai/details/publication/pub.1082829483 schema:CreativeWork
107 https://doi.org/10.1002/ajh.2830060204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024110883
108 rdf:type schema:CreativeWork
109 https://doi.org/10.1016/0002-9149(94)90474-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033229922
110 rdf:type schema:CreativeWork
111 https://doi.org/10.1016/0002-9610(91)90183-e schema:sameAs https://app.dimensions.ai/details/publication/pub.1023228319
112 rdf:type schema:CreativeWork
113 https://doi.org/10.1016/0140-6736(90)92558-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1021469486
114 rdf:type schema:CreativeWork
115 https://doi.org/10.1016/0268-960x(88)90032-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053187605
116 rdf:type schema:CreativeWork
117 https://doi.org/10.1016/0735-1097(93)90041-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1030203168
118 rdf:type schema:CreativeWork
119 https://doi.org/10.1016/0735-1097(94)90634-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025598401
120 rdf:type schema:CreativeWork
121 https://doi.org/10.1016/0735-1097(95)00500-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043295572
122 rdf:type schema:CreativeWork
123 https://doi.org/10.1016/s0002-9149(96)90072-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011240930
124 rdf:type schema:CreativeWork
125 https://doi.org/10.1016/s0140-6736(96)10172-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049786560
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1016/s0140-6736(96)10452-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044275166
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1016/s0735-1097(96)80531-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052868078
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1016/s0735-1097(96)81843-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031889596
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1016/s0735-1097(97)84111-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054658363
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1016/s0889-8588(18)30515-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1077282481
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1021/jm00042a007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055933431
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1056/nejm197607292950501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047017208
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1056/nejm197903223001215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042550389
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1056/nejm199011223232114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023817201
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1056/nejm199105303242206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048753262
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1056/nejm199404073301402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040255966
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1056/nejm199706123362401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017752478
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1084/jem.107.5.711 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014069980
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1097/00000441-197402000-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019682362
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1097/00007611-198805000-00018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079707891
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1111/j.1365-2141.1995.tb08346.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010142341
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1136/ard.22.6.440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043678204
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1161/01.cir.91.8.2151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063336211
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1161/01.cir.94.5.899 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063337444
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1161/01.cir.94.5.906 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063337445
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1161/01.cir.95.4.846 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063337843
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1161/01.cir.97.4.340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034721348
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1378/chest.108.4_supplement.258s schema:sameAs https://app.dimensions.ai/details/publication/pub.1042476702
172 rdf:type schema:CreativeWork
173 https://doi.org/10.7326/0003-4819-126-4-199702150-00010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073701186
174 rdf:type schema:CreativeWork
175 https://www.grid.ac/institutes/grid.62560.37 schema:alternateName Brigham and Women's Hospital
176 schema:name TIMI Study Chairman’s Office, Brigham and Women’s Hospital, Boston, Massachusetts, USA
177 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...